Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- NAUT
- Price
- 0.74
- Stock movement down
- -0.03 (-3.95%)
- Company name
- Nautilus Biotechnology Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 93.23M
- Ent value
- 125.09M
- Price/Sales
- 11.35
- Price/Book
- 0.42
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -71.88%
- 3 year return
- -42.22%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-05-29
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
NAUT does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 11.35 |
| Price to Book | 0.42 |
| EV to Sales | 15.23 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 125.56M |
| EPS (TTM) | -0.56 |
| FCF per share (TTM) | -0.49 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 8.21M |
| Gross profit (TTM) | 1.82M |
| Operating income (TTM) | -78.52M |
| Net income (TTM) | -70.21M |
| EPS (TTM) | -0.56 |
| EPS (1y forward) | -0.74 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 22.19% |
| Operating margin (TTM) | -956.16% |
| Profit margin (TTM) | -854.97% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 4.41M |
| Net receivables | 0.00 |
| Total current assets | 144.21M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 39.81M |
| Total assets | 259.70M |
| Accounts payable | 1.49M |
| Short/Current long term debt | 31.57M |
| Total current liabilities | 8.66M |
| Total liabilities | 36.27M |
| Shareholder's equity | 223.43M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -58.74M |
| Capital expenditures (TTM) | 2.28M |
| Free cash flow (TTM) | -61.02M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -31.42% |
| Return on Assets | -27.03% |
| Return on Invested Capital | -30.35% |
| Cash Return on Invested Capital | -26.37% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.77 |
| Daily high | 0.79 |
| Daily low | 0.74 |
| Daily Volume | 131K |
| All-time high | 22.43 |
| 1y analyst estimate | 3.44 |
| Beta | 1.04 |
| EPS (TTM) | -0.56 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| NAUT | S&P500 | |
| Current price drop from All-time high | -96.69% | -4.11% |
| Highest price drop | -97.02% | -56.47% |
| Date of highest drop | 6 May 2025 | 9 Mar 2009 |
| Avg drop from high | -74.20% | -11.06% |
| Avg time to new high | 75 days | 12 days |
| Max time to new high | 1081 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
93.23M
Marketcap category
Small-cap
Description
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.
Employees
161
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page